
### [NCIT:C5585](http://purl.obolibrary.org/obo/NCIT_C5585)
**Label:** Skin Sarcoma

**Subclasses:** [NCIT:C5615](http://purl.obolibrary.org/obo/NCIT_C5615) (Cutaneous Liposarcoma), [NCIT:C5576](http://purl.obolibrary.org/obo/NCIT_C5576) (Cutaneous Undifferentiated Pleomorphic Sarcoma), [NCIT:C27719](http://purl.obolibrary.org/obo/NCIT_C27719) (Cutaneous Radiation-Related Angiosarcoma), [NCIT:C4489](http://purl.obolibrary.org/obo/NCIT_C4489) (Skin Angiosarcoma), [NCIT:C4484](http://purl.obolibrary.org/obo/NCIT_C4484) (Cutaneous Leiomyosarcoma), [NCIT:C4490](http://purl.obolibrary.org/obo/NCIT_C4490) (Skin Lymphangiosarcoma), [NCIT:C9112](http://purl.obolibrary.org/obo/NCIT_C9112) (Classic Kaposi Sarcoma), [NCIT:C3550](http://purl.obolibrary.org/obo/NCIT_C3550) (Skin Kaposi Sarcoma), [NCIT:C40379](http://purl.obolibrary.org/obo/NCIT_C40379) (Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema), 

**Class expressions from DL-Learner:**

- [UBERON:0002097](http://purl.obolibrary.org/obo/UBERON_0002097) (skin of body) 53.85%
- [UBERON:0002067](http://purl.obolibrary.org/obo/UBERON_0002067) (dermis) 53.85%
- Thing 52.89%
- [NCIT:C12964](http://purl.obolibrary.org/obo/NCIT_C12964) (Connective and Soft Tissue) 39.32%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39569](http://purl.obolibrary.org/obo/NCIT_C39569) (Cytoplasmic Protrusions Present))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39565](http://purl.obolibrary.org/obo/NCIT_C39565) (Coarse Azurophilic Granules Present))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3950](http://purl.obolibrary.org/obo/NCIT_C3950) (Oral Mucosa Lobular Capillary Hemangioma))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3939](http://purl.obolibrary.org/obo/NCIT_C3939) (Bannayan Syndrome))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39301](http://purl.obolibrary.org/obo/NCIT_C39301) (CD4+/CD56+ Neoplastic Medium-Sized Cell))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39300](http://purl.obolibrary.org/obo/NCIT_C39300) (Precursor Natural Killer Cell))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39294](http://purl.obolibrary.org/obo/NCIT_C39294) (Schistosoma Hematobium Infection))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39293](http://purl.obolibrary.org/obo/NCIT_C39293) (Helicobacter Pylori Infection))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39291](http://purl.obolibrary.org/obo/NCIT_C39291) (HHV8 Infection))) 39.20%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39278](http://purl.obolibrary.org/obo/NCIT_C39278) (Thrombin/Protease-Activated Receptor Signaling Pathway))) 39.20%


